Deformulation and its relevance to bioequivalence studies

In this webinar, senior formulation scientist Dr. Andrew Deacon, from Concept Life Sciences, will demonstrate the importance of deformulation or ‘reverse engineering’ to elucidate the analytical approaches that can be applied in the detection of active pharmaceutical ingredients (APIs) and excipients. Deacon will show how assessment of the physicochemical properties of APIs and excipients present in formulations is critical when developing equivalent generic formulations, detailing the role of deformulation in formulation deconstruction and reconstruction to ensure bioequivalence of generic products.

Speakers

  • Dr Andrew Deacon - Senior Formulation Scientist, Concept Life Sciences
  • Ellen Simms - Editorial Assistant, SelectScience

More information

Learning objectives:


  • Find out what deformulation is and why it’s important
  • Understand the role of deformulation prior to a bioequivalence study
  • Learn the criteria to consider in the separation of formulation components
  • Learn about analytical approaches from real case studies


This webinar will benefit:


  • Formulation scientists
  • Pharmaceutical scientists interested in deformulation
  • Researchers working on formulation development